Back to
NORTHERN TRUST CORP
VIVO17 quarters
Position history for
NORTHERN TRUST CORP's holdings in MERIDIAN BIOSCIENCE INC
As of its Q4 2022 13F, Northern Trust held 551,260 shares of VIVO (Meridian Bioscience), worth $18.3M. Northern Trust's 13F filings listed VIVO from Q1 2019 to Q4 2022, 16 quarterly filings.
Final Value
$0
Final Shares
0
Total Value Change
-$10.5M
Total Shares Change
-597,786
Quarter-by-Quarter History
Other major holders of VIVO: EARNEST PARTNERS LLC